A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.

NCT07357675 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease (CAD)
Coronary Artery Bypass Graft Surgery(CABG)

Interventions

DRUG: EA-230 90mg/kg/hour
DRUG: Placebo

Sponsor

EBI Anti Sepsis BV

Collaborators

[object Object]